Karuna Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KRTX research report →
About the company
Operating as a clinical-stage biopharmaceutical firm, Karuna Therapeutics, Inc. is dedicated to pioneering innovative therapies for individuals afflicted by psychiatric and neurological disorders. Its primary investigational compound, KarXT, is an oral agent designed to modulate muscarinic receptors.
- CEO
- William Meury
- IPO
- 2019
- Employees
- 339
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $12.60B
- P/E
- -28.12
- P/S
- 19264.95
- P/B
- 9.72
- EV/EBITDA
- -25.21
- Div Yield
- 0.00%
- Gross Margin
- -160.09%
- Op Margin
- -75653.98%
- Net Margin
- -66311.93%
- ROE
- -36.44%
- ROIC
- -38.93%
- Revenue
- $654.00K · -93.85%
- Net Income
- $-433,680,000 · -56.94%
- EPS
- $-11.73 · -34.21%
- Op Income
- $-494,777,000
- FCF YoY
- -69.81%
- 52W High
- $329.99
- 52W Low
- $158.38
- 50D MA
- $317.38
- 200D MA
- $228.31
- Beta
- 1.15
- Avg Volume
- 971.83K
Get TickerSpark's AI analysis on KRTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 24 | Wheadon David E. | sell | 25,000 |
| Mar 18, 24 | Wheadon David E. | sell | 8,500 |
| Mar 18, 24 | Wheadon David E. | sell | 990 |
| Mar 18, 24 | Wheadon David E. | sell | 5,000 |
| Mar 18, 24 | Wheadon David E. | sell | 1,904 |
| Mar 18, 24 | Torres Denice | sell | 990 |
| Mar 18, 24 | Torres Denice | sell | 5,000 |
| Mar 18, 24 | Torres Denice | sell | 1,904 |
| Mar 18, 24 | Torres Denice | sell | 8,500 |
| Mar 18, 24 | Torres Denice | sell | 25,000 |
Our KRTX coverage
Recent articles, reports, and earnings notes.
No research on KRTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KRTX report →Similar companies
Peers in the same neighborhood.